TCL Archive Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming June 15, 1979
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86 February 6, 1987
TCL Archive NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved February 26, 1993
